Home
>
National Drug Code (NDC)
>
VOTRIENT
VOTRIENT - 0173-0804-61 - (pazopanib hydrochloride)
Drug Information of VOTRIENT
| Product NDC: | 0173-0804 |
| Proprietary Name: | VOTRIENT |
| Non Proprietary Name: | pazopanib hydrochloride |
| Active Ingredient(s): | 200 mg/1 & nbsp; pazopanib hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VOTRIENT
| Product NDC: | 0173-0804 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022465 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20091019 |
Package Information of VOTRIENT
| Package NDC: | 0173-0804-61 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (0173-0804-61) |
NDC Information of VOTRIENT
| NDC Code | 0173-0804-61 |
| Proprietary Name | VOTRIENT |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (0173-0804-61) |
| Product NDC | 0173-0804 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pazopanib hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20091019 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | PAZOPANIB HYDROCHLORIDE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Kinase Inhibitor [EPC] |
